Skip to main content
. 2016 May 19;11(5):e0155560. doi: 10.1371/journal.pone.0155560

Table 4. Median and mean Diabetes Risk Score, prevalence of Increased DM risk and assessed risk factors of diabetes.

Parameter All participants (n = 200) HAART group (n = 100) HAART-naïve group (n = 100) P-valuea
DRS (%)
Median (%) 1.99 2.30 1.62 0.002b
IQRc(%) 0.15–6.40 1.13–8.28 0.58–4.06
Increased DM risk (DRS ≥ 7)
Prevalence, n (%) 48 (24%) 31 (31%) 17 (17%) 0.020
95% CI, (%) 18.26–30.53 22.13–41.03 10.23–25.82
History of smoking
Smoker 3 (1.5%) 2 (2%) 1 (1%) 0.844
Used to smoke 8 (4%) 4 (4%) 4 (4%)
Non-smoker 189 (94.5%) 94 (94%) 95 (95%)
Treatment of HTN
No HTN medications 143 (71.5%) 62 (62%) 81 (81%) 0.003
On HTN medications 57 (28.5%) 38 (38%) 19 (19%)
BMI (Kg/m2)
<25 119 (59.5%) 50 (50%) 69 (69%) 0.016
25–27.49 50 (25%) 29 (29%) 21 (21%)
27.5–29.99 31 (15.5%) 21 (21%) 10 (10%)
Family history of DM
No first degree family members with diabetes 189 (94.5%) 91 (91%) 98 (98%) 0.055
Parent or sibling with diabetes mellitus 11 (11%) 9 (9%) 2 (2%)
Use of steroidsd
Not on steroids 200 (100%) 100 (100%) 100 (100%) -
On steroids 0 (0%) 0 (0%) 0 (0%)

a P-value for Chi-square test comparing the HAART and HAART-naïve groups

bP-value for Wilcoxon rank sum (Mann-Whitney) test comparing the HAART and HAART-naïve groups

cIQR—Interquartile range

dNo participant reported using steroids